ZYSTIP
DEAD

Serial Number

87057370

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Jun 2, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ZYSTIP Trademark

Serial Number: 87057370

ZYSTIP is a trademark filed by NOVARTIS AG on June 2, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,173 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

June 2, 2016

Registration Date

Not Registered

Published for Opposition

October 25, 2016

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 23, 2018 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 23, 2018 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2017 EXRA
SOU EXTENSION 2 GRANTED
Dec 18, 2017 EX2G
SOU EXTENSION 2 FILED
Dec 18, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 18, 2017 EEXT
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 2, 2017 AITU
AMENDMENT AFTER NOA NOT ENTERED
Oct 24, 2017 INOA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Oct 24, 2017 EPPA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 9, 2017 EXRA
SOU EXTENSION 1 GRANTED
Jun 7, 2017 EX1G
SOU EXTENSION 1 FILED
Jun 7, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 7, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 13, 2016 CNSA
ASSIGNED TO EXAMINER
Sep 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2016 NWOS
NEW APPLICATION ENTERED
Jun 6, 2016 NWAP